VIDUS OCULAR
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. It offers Aquashunt, which is a shunt to treat glaucoma, the cause of blindness in the United States. The company is based in the United States. As of May 7, 2008, Vidus Ocular, Inc. operates as a subsidiary of Opko Health, Inc.
Similar Organizations
Capillect
Capillect develops a minimally invasive blood collection device to be implemented in the current blood sampling workflows.
Eyoca Medical
Eyoca Medical develops a disposable device for the treatment of chronic total occlusion.
Ocuelar
Ocuelar develops smart cap technology that can measure true medication compliance for glaucoma patients.
Current Employees Featured
More informations about "Vidus Ocular"
Vidus Ocular - Products, Competitors, Financials, Employees ...
Vidus Ocular develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. Use the CB Insights Platform to explore Vidus Ocular's …See details»
Vidus Ocular - Crunchbase Company Profile & Funding
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. It offers Aquashunt, which is a shunt to treat glaucoma, …See details»
Vidus Ocular 2025 Company Profile: Valuation, Investors
Information on acquisition, funding, investors, and executives for Vidus Ocular. Use the PitchBook Platform to explore the full profile.See details»
OPKO Health Acquires Company Developing Novel Glaucoma …
May 7, 2008 "We designed Aquashunt with the goal of translating our extensive experience in treating glaucoma into a new type of therapy that would leverage physiologic principles to treat …See details»
Vidus Ocular - VentureRadar
Vidus Ocular was developing the Aquashunt,â„¢ a glaucoma drainage device that can relieve elevated pressure in patients with or at risk for the development of glaucoma.See details»
Opko Acquires Vidus Ocular | Mergr M&A Deal Summary
Vidus Ocular, Inc. is a developer of Aquashunt (TM), an innovative shunt to treat glaucoma, the second cause of blindness. Aquashunt is an implantable physiologic device that is designed to …See details»
Vidus Ocular Inc - Company Profile and News - Bloomberg Markets
Company profile page for Vidus Ocular Inc including stock price, company news, executives, board members, and contact informationSee details»
Vidus Ocular - VentureRadar
Vidus Ocular was developing the Aquashunt,â„¢ a glaucoma drainage device that can relieve elevated pressure in patients with or at risk for the development of glaucoma. It was …See details»
Wednesday, April 23, 2008 Vidus Ocular, Inc. - CURE News
Wednesday, April 23, 2008 Vidus Ocular, Inc. Followed by networking, refreshments & wine bar Vidus Ocular, Inc. is an early-stage company developing the AquashuntTM — a glaucoma …See details»
Vidus Ocular - Ownership and Business Overview | Mergr
Vidus Ocular, Inc. is a developer of Aquashunt (TM), an innovative shunt to treat glaucoma, the second cause of blindness. Aquashunt is an implantable physiologic device that is designed to …See details»
OPKO Health acquires company developing glaucoma shunt
Jun 5, 2008 Miami- OPKO Health has acquired Vidus Ocular, a privately held company developing a shunt (Aquashunt) to treat glaucoma. The patented device was designed by M. …See details»
Vidus Ocular - Updates, News, Events, Signals & Triggers
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. ItSee details»
Vidus Ocular Inc Company Profile, Financial and Strategic
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. It offers Aquashunt, which is a shunt to treat glaucoma, …See details»
Vidus Ocular - Crunchbase
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. ItSee details»
Opko acquires Aquashunt maker - Ophthalmology Times
May 16, 2008 Vidus Ocular, Inc, the developer of the Aquashunt device for glaucoma, has been acquired by OPKO Health, Inc. Aquashunt is an implantable device designed to reduce …See details»
Vidus Ocular - Contacts, Employees, Board Members, Advisors
Vidus Ocular, Inc. develops an implantable physiologic device that is designed to address the shortcomings of glaucoma treatments. ItSee details»
Opko acquires Vidus Ocular - | BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, …See details»
Vidus Ocular - Headquarter Location, Corporate Office Address …
About Vidus Ocular is Biotechnology in United States that focus on United States business. Founded in 1992. They cover business area such as Provider, medical service, Wilmington, …See details»
OPKO Health Acquires Company Developing Novel Glaucoma …
May 8, 2008 OPKO Health, Inc. (Amex: OPK) today announced that it has acquired Vidus Ocular, Inc., a privately held company that is developing Aquashunt(TM), an innovative shunt …See details»
Vidus Ocular CEO, Founder, Key Executive Team, Board of …
Explore {Vidus Ocular's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»